XTL Biopharmaceuticals | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)

Xtl生物製藥 | SC 13G/A：超過5%持股股東披露文件(修正)